Press room

IDDI in the Media.

Read the articles related to our know-how and expertise in clinical research and how we optimize the design and conduct of clinical trials.

Personalized Medicine: A Work in Progress

Press
News & Events
Press room

Dr. Everardo Saad, Medical Director of IDDI contributed to an article on Personalized Medicine published in the June issue of PharmaVOICE, both digital and printed. “Advances in big-data analytics are increasingly being employed to extract targeted information with the potential […]

Read more

Clinical Development Trends

May 25, 2021

Press
News & Events
Press room

In addition to pharmaceutical and biopharmaceutical sponsors outsourcing clinical trials to Contract Research Organizations (CROs) to gain flexibility and speed the drug development process, key factors impacting market trends include technology and digital modernization of clinical trials, advanced therapies and […]

Read more

Considerations on the mechanics and sample sizes for early trials of targeted agents and immunotherapy in oncology

Press
News & Events
Press room

Read article on trial design and sample sizes for early trials Written by Elisabeth Coart and Everardo D. Saad, Consulting Services & Research, IDDI ABSTRACT Introduction: Precision medicine is impacting clinical practice and drug development in oncology, promoting notable changes […]

Read more

The Importance of Early Phase Trials in Precision Oncology

Press
News & Events
Press room

Nowadays, drug development in oncology is largely centered on the basic premise of precision medicine, according to which targeted agents are used based on the expression of predictive biomarkers. Even though late-phase trials of precision oncology are undergoing transformations, we […]

Read more

Commanders & Chiefs: Clinical Services C-Suite – Pharmavoice

Press
Press room

IDDI contributed to the Pharmavoice article: Commanders & Chiefs: Clinical Services C-Suite, February, 2021 CROs and other clinical services companies have positioned themselves to be valued partners to biopharma companies. The executives of these companies are charged with not only […]

Read more

Statistical Considerations for Trials in Adjuvant Treatment of Colorectal Cancer

Press
News & Events
Press room

Improvements in the treatment of patients with cancer largely depend on clinical trials comparing a new intervention with a previous standard of care. This is not different when it comes to improving adjuvant (postoperative) and neoadjuvant (preoperative) treatment for colorectal […]

Read more

Finding the one: How to choose a Clinical Partner in Sea of Service Providers

Press
Press room

What should companies look for when selecting a CRO clinicalpartner?  Just one in ten drug candidates are successful in clinical trials, and the number of products making it from development to approval is currently at an all-time low. It means […]

Read more

Integration of Biomarker Validation in Clinical Development in Oncology

Press

The development and qualification of biomarkers are keys to the future of drug development and precision medicine, particularly in oncology. Read IDDI Article published in Applied Clinical Trials.  Precision medicine relies on validated biomarkers that allow classification of patients by […]

Read more

IDDI in Contract Pharma

Press
Press room

Insight on the pharma and biopharma trends impacting CROs, Outsourcing in today’s market, and advances in clinical research. READ IDDI ARTICLE PUBLISHED IN CONTRACT PHARMA ! Kristin Brooks, Contract Pharma 04.27.20 Serge Bodart of IDDI provides insight on the pharma […]

Read more

Surrogate endpoints create potential, require statistical validation

Press room

Transforming statistical data into a surrogate endpoint can enable comprehension of trial results sooner than usual, but few make the cut after formal validation, says drug development expert and DIA panelist. READ ARTICLE HERE Interview of Dr. Marc Buyse, ScD, […]

Read more